Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG-4592 vs epoetin in dialysis CKD anemia
CTR20150608Phase 3Completed
- Sponsor
- Fapon Biopharma
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of renal disease, sponsored by Fapon Biopharma. Started Sep 2015; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on CTR20150608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150608.